Aetna
Aetna Aetna
Specialty Pharmacy Clinical Policy Bulletins
Aetna Non-Medicare Prescription Drug Plan
Subject: Specialty Quantity Limit Epidiolex 2611-H P2023

Drug
EPIDIOLEX  (cannabidiol)


Policy:

      I.  PROGRAM DESCRIPTION

          The standard limit is designed to allow a quantity sufficient for
          the most common uses of the medication. If the member’s plan
          allows a quantity limit exception review for the requested
          medication, coverage of an additional quantity may be provided
          up to the exception limit with prior authorization.


    II.  COVERED QUANTITIES

Medication

Standard Limit

  Exception   Limit*

     FDA-recommended dosing

 

  Epidiolex
  100 mg/mL
  oral solution

 

  800 mL
  per 30 days

 

  1500 mL
  per 30 days

Seizures Associated with Lennox-Gastaut Syndrome or Dravet Syndrome
  •  Initial dose: 2.5 mg/kg twice
     daily. After one week,
     increase to a maintenance
     dose of 5 mg/kg twice daily.
     Increase in weekly
     increments of 2.5 mg/kg
     twice daily.
  •  Maximum dose: 10 mg/kg
     twice daily.

Seizures Associated with Tuberous Sclerosis Complex
  •  Initial dose: 2.5 mg/kg twice
     daily. Increase to a
     maintenance dose of 12.5
     mg/kg twice daily. Increase
     in weekly increments of 2.5
     mg/kg twice daily.

Dose adjustment
  •  With a strong inducer of
     CYP3A4 or CYP2C19: Dose
     increase of Epidiolex may be
     considered based on clinical
     response and tolerability.

*Coverage up to the exception limit may be provided with prior authorization via the Specialty Post Limit Quantity Exception Criteria for approval.


Place of Service:

Outpatient

The above policy is based on the following references:
  1. Epidiolex [package insert]. Palo Alto, CA: Jazz Pharmaceuticals, Inc.; January 2023.
Copyright Aetna Inc. All rights reserved. Pharmacy Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.

October 15, 2023
Aetna
Skip Past Footer Links
Company Information   |   Site Map Aetna.com Home   |   Help   |   Contact Us   |   Search
Web Privacy Statement   |   Legal Statement   |   Privacy Notices   |   Member Disclosure

Back to top